FLC Business

FLC Region

Security Lab



2020 Vision Place
Bethesda, MD 20892-3655
United States

Laboratory Representative


The National Eye Institute (NEI) was established by Congress in 1968 to protect and prolong the vision of the American people. As one of the Federal government's National Institutes of Health (NIH), the NEI conducts and supports research that helps prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages. NEI-supported research has advanced our knowledge of how the visual system functions in health and disease. Vision research is supported by the NEI through approximately 1600 research grants and training awards made to scientists at more than 250 medical centers, hospitals, universities, and other institutions across the country and around the world. The NEI also conducts laboratory and patient-oriented research at its own facilities located on the NIH campus in Bethesda, Maryland. Because of continued Congressional and public support, the national investment in vision research has yielded substantial dividends to treat many potentially blinding eye diseases.


Part of the NEI mission is to develop public and professional education programs that help prevent blindness, reduce visual impairment, and increase awareness of services and devices that are available for people with low vision. To meet these objectives, the NEI has established the National Eye Health Education Program (NEHEP), a partnership of over 65 professional, civic, and voluntary organizations and government agencies concerned with eye health. The program represents an extension of the NEI's support of vision research, where results are disseminated to health professionals, patients, and the public. The NEI is also the lead Federal agency for the vision and hearing chapter in Healthy People 2010, the nation's blueprint to improve public health.

Tech Areas

Available Technologies
Displaying 1 - 10 of 16
Animal Model for Age-Related Macular Degeneration and Methods for Use Thereof
Devices for Aseptic Lyophilization of Biological Samples
Devices for Improved Tissue Cryopreservation and Recovery
Ex-vivo Production of Regulatory B-Cells (Breg) for Use in Auto-immune Indications
Immortalized Transformed Lymphoblastoid Cell Lines from Patients with François-Neetens Mouchetée Fleck Corneal Dystrophy (CFD)
Macrophage Migration Inhibitory Factor (MIF)
Macrophage Migration Inhibitory Factor (MIF)
Methods of Treating Age-Related Macular Degeneration
Nitisinone for Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Novel Methods for Generating Retinal Pigment Epithelium Cells from Induced Pluripotent Stem Cells



These investigator-initiated awards facilitate cooperative research and development between small business concerns (not less than 40% of the proposed work) and research institutions (not less than 30% of the work), where commercialization is the primary goal of the project. From time to time the NEI solicits STTR applications in a particular program area through an FOA. Phase I awards normally may not exceed $150,000 total costs for a one year period. Phase II awards normally may not exceed $1,000,000 total costs over a two year period.

•R41 Phase I Small Business Technology Transfer Grant

•R42 Phase II Small Business Technology Transfer Grant

No Programs for this lab
Displaying 1 - 2 of 2
Genetic Engineering Facility
NEI Core Facilities (Various)
No Equipment for this lab
No publications for this lab
No awards for this lab
No success stories for this lab
Submit an Success Story